b'NOW APPROVEDFor a 6 th IndicationFirst FDA Approval in 2017Learn more atdupixenthcp.com 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.DUPIXENT is a registered trademark of Sanofi Biotechnology.US.DUP.24.10.0086 10/24'